Current and historical daily PE Ratio for Zenith Capital Corp (
) from 2020 to Jun 03 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Zenith Capital stock (ZHCLF) PE ratio as of Jun 03 2024 is 0.
More Details
Zenith Capital Corp (ZHCLF) PE Ratio (TTM) Chart
Zenith Capital Corp (ZHCLF) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 0
- 1
| Zenith Capital PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Zenith Capital Corp (ZHCLF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Zenith Capital Corp
NAICS : 541714
SIC : 3741
ISIN : CA98935N1033
Share Class Description:
ZHCLF: Ordinary SharesDescription
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers